Financials

%ChgLast 12MReverse

	FY202312/31/2023	FY202412/31/2024	FY202512/31/2025	Last 12M03/31/2026
Cash and Cash Equivalents	3.6	4.7	2.0	1.2
Short Term Investments	-	-	-	-
Cash and Short Term Investments	3.6	4.7	2.0	1.2
Net Receivables	1.5	0.6	0.0	0.1
Inventory	-	-	-	-
Other Current Assets	0.2	0.1	0.1	0.1
Total Current Assets	6.4	5.7	2.3	1.7
Property, Plant & Equipment	20.5	22.9	20.9	20.8
Long Term Investments	1.6	1.6	1.3	4.8
Other Non-Current Assets	0.1	0.0	0.0	0.0
Total Non-Current Assets	22.1	24.5	22.2	25.6
Total Assets	28.5	30.2	24.5	27.3
Account Payables	6.2	22.3	13.1	11.8
Short Term Debt	-	6.3	6.8	6.6
Deferred Revenue	-	-	-	0.5
Other Current Liabilities	-	0.8	-	1.0
Total Current Liabilities	8.7	29.6	21.1	20.0
Long Term Debt	6.3	7.4	-	-
Other Non-Current Liabilities	-	-	0.7	1.6
Total Non-Current Liabilities	6.3	7.4	0.7	1.6
Total Liabilities	15.1	37.0	21.8	21.6
Common Stock	0.0	0.0	0.0	0.0
Retained Earnings	-70.5	-100.6	-108.5	-105.0
Total Stockholders Equity	13.5	-6.8	2.8	5.8
Total Liabilities and Equity	28.5	30.2	24.5	27.3

HCW Biologics Inc.(HCWB US)